| Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 
β2 agonistsynthetic sympathomimetricsynthetic catecholamines |  | 
        |  | 
        
        | Term 
 
        | Terbutaline - description |  | Definition 
 
        | stimulates β2 receptors in smooth muscles of bronchial tree - activates intracellular enzyme adenyl cylase which converts ATP to c-AMP increases c-AMP levels is assoc. w/ smooth muscle relaxation and inhibition of mediation release from mast cells --> bronchial dilation |  | 
        |  | 
        
        | Term 
 
        | Terbutaline - indications |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Terbutaline - onset and duration |  | Definition 
 
        | onset - within minutes duration -  4-6 hours |  | 
        |  | 
        
        | Term 
 
        | Terbutaline - Contraindications |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Terbutaline - adverse reactions |  | Definition 
 
        | tachycardia (small amount of β1 effect) skeletal muscle tremors - inhaled med concentrates in lungs, oral has increased dosage - more likely to cause tremors |  | 
        |  | 
        
        | Term 
 
        | Terbutaline - D + A Adults |  | Definition 
 
        | 0.25 mg SQ may repeat in 20-30 min alt. route 1-2 mg in 3 cc NSS nebulized |  | 
        |  | 
        
        | Term 
 
        | Terbutaline - D + A Pediatric |  | Definition 
 
        | 0.01 mg/kg (max 0.25 cc) SQ - may repeat in 20-30 min |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | longer duration than epi wehn given SQ greater bronchodilation prop.s, less burning pain upon injection, seldom used in older adult patients (>30 y/o) |  | 
        |  |